DJIA 16,374.76 23.38 0.14%
NASDAQ 4,733.50 -16.48 -0.35%
S&P 500 1,951.13 2.27 0.12%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

Cancer Stocks: 2 to Sell, 1 to Buy

Advaxis, Ariad Pharmaceuticals, and Exelixis Inc. are three cancer fight companies that could generate out-sized gains for investors. A deeper look, however, suggests that only one company is a compelling buy right now.

Cancer Stocks: 2 to Sell, 1 to Buy

Advaxis, Ariad Pharmaceuticals, and Exelixis Inc. are three cancer fight companies that could generate out-sized gains for investors. A deeper look, however, suggests that only one company is a compelling buy right now.

What's Happening At The ASCO Conference?

Michael Price Invests in 11 Companies in First Quarter

Stifel Talks 5 Biotech Stocks

ARIAD (ARIA) Q1 Loss Wider than Estimates; Iclusig Grows - Analyst Blog

ARIAD (ARIA) Q1 Loss Wider than Estimates; Iclusig Grows - Analyst Blog

ARIAD (ARIA) Q1 Loss a Penny Wider than Expected - Tale of the Tape

ARIAD Pharmaceuticals (ARIA) Harvey J. Berger on Q1 2015 Results - Earnings Call Transcript

Interesting ARIA Put Options For June 26th

ARIAD Pharmaceuticals (ARIA) Q1 2015 Results - Earnings Call Webcast

See More Articles...